From October 1, 2023 to December 31, 2023, the company has repurchased 1,994,667 shares, representing 0.85% for $928.79 million. With this, the company has completed the repurchase of 508,124,069 shares, for $47,187.3 million under the buyback announced on October 26, 2004.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
553.1 USD | +4.24% |
|
+4.52% | +17.30% |
15/07 | Truist Securities Adjusts Price Target on Elevance Health to $620 From $600, Maintains Buy Rating | MT |
11/07 | 50 billion dollars - What US insurers pocketed for fictitious illnesses | ![]() |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.30% | 129B | |
+13.44% | 96.5B | |
-13.59% | 47.67B | |
-6.87% | 36.88B | |
-14.94% | 18.01B | |
-19.31% | 2.86B | |
+14.63% | 1.89B | |
+81.70% | 859M |
- Stock Market
- Equities
- ELV Stock
- News Elevance Health, Inc.
- Tranche Update on Elevance Health, Inc.'s Equity Buyback Plan announced on October 26, 2004.